Apurvasena Parikh Selected Research

Apurvasena Parikh Research Topics

3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 11/2021
3	Neoplasms (Cancer) 01/2021 - 11/2018
1	Squamous Cell Carcinoma of Head and Neck 02/2022
1	Disease Progression 02/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021
1	Hypoalbuminemia 01/2021
1	Nausea 01/2021
1	Menorrhagia 12/2020
1	Pain (Aches) 12/2020
1	Leiomyoma (Uterine Fibroids) 12/2020
1	Endometriosis 12/2020
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2018
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018
1	Hepatitis C 10/2016
1	Infections 10/2016
1	Sickle Cell Anemia (Hemoglobin S Disease) 11/2011

4	telisotuzumab vedotinIBA 10/2023 - 11/2018
3	budigalimabIBA 02/2022 - 01/2021
3	Immunoconjugates (Immunoconjugate)IBA 11/2021 - 11/2018
1	ErbB Receptors (EGF Receptor)IBA 10/2023
1	Proteins (Proteins, Gene)FDA Link 10/2023
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2023
1	LigandsIBA 02/2022
1	Aligeron (AS 2)IBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	rovalpituzumab tesirineIBA 01/2021
1	elagolixIBA 12/2020
1	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 12/2020
1	Estradiol (Delestrogen)FDA LinkGeneric 12/2020
1	Norethindrone Acetate (Norlutate)FDA LinkGeneric 12/2020
1	venetoclaxIBA 01/2018
1	Antiviral Agents (Antivirals)IBA 10/2016
1	Tacrolimus (Prograf)FDA LinkGeneric 10/2016
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2016
1	vanillinIBA 11/2011

1	Duration of Therapy 02/2022
1	Liver Transplantation 10/2016